Ian N. Bruce

, United Kingdom

Ian Bruce is a National Institute of Health Research (NIHR) Senior Investigator and Professor of Rheumatology at the Centre for Musculoskeletal Research, University of Manchester. He is Director of The NIHR Manchester Biomedical Research Centre. Professor Bruce qualified in medicine from Queen’s University Belfast in 1988 and gained his MRCP in 1991. He trained in medicine and rheumatology in Northern Ireland and completed his MD thesis on the pathogenesis of systemic vasculitis in 1995. He was the Geoff Carr Lupus Fellow at the University of Toronto with Murray Urowitz and Dafna Gladman (1996-98) before moving to Manchester in 1998. Professor Bruce is former Chair of the Systemic Lupus International Collaborating Clinics (SLICC) group and a member of the British Isles Lupus Assessment Group (BILAG). He leads the BILAG Biologics Register for SLE and is Chief Investigator of the MASTERPLANS consortium, an MRC-funded stratified medicine consortium focusing on SLE. He also serves on Data Safety Monitoring Committees in several commercial and academic clinical trials and s Chair of the Astra Zeneca Anifrolumab Steering Group. Professor Bruce’s research is focused on the association between inflammatory rheumatic diseases and premature atherosclerosis/coronary heart disease as well as stratified medicine in SLE.


From clinical trial endpoints to clinical practice: what does it mean for the patient? 03 June 2020 18:45 - 19:10 Add to calendar More ...
The future of SLE: where do we go next? 03 June 2020 19:35 - 19:45 Add to calendar More ...